IPO Guru
Molbio Diagnostics Logo

Molbio Diagnostics IPO Subscription Status

The Molbio Diagnostics IPO has been subscribed 70.26x times overall. Retail investors have shown interest with bids for 12.96x the shares available. The Non-Institutional Investor (NII) category has been subscribed 49.8x. Within NII, Big HNI (B-HNI) subscribed 50.82x and Small HNI (S-HNI) subscribed 47.76x. Qualified Institutional Buyers (QIBs) have subscribed 186.39x. Data last updated on 08 Sep, 01:37 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 10 Aug, 2026 and closes on 12 Aug, 2026. The shares are expected to list on stock exchanges on 17 Aug, 2026.

Total Subscription
70.26 x

26,07,168 applications

QIB 186.39x
BHNI 50.82x
SHNI 47.76x
Retail 12.96x
Employee 13.28x

Live Bidding

Category Bid Details TIMES
QIB
43,33,82,148
of 23,25,145
139 applications
34,973.94 Cr
186.39x
NII
8,68,40,604
of 17,43,860
1,52,244 applications
7,008.04 Cr
49.8x
Retail
5,27,19,318
of 40,69,005
24,54,316 applications
4,254.45 Cr
12.96x
Employee
2,72,466
of 20,519
469 applications
21.99 Cr
13.28x
TOTAL
57,32,14,536
26,07,168 applications
46,258.41 Cr
70.26x

Last Updated: 08 Sep 2026, 01:37 PM

Molbio Diagnostics IPO Basis of Allotment

Final figures published by the registrar, after technical rejections. Allotment price ₹807, employees ₹731.

FINAL
Applications
26,07,201
Allottees
2,33,443
Overall Odds
1 in 11
Amount Collected
₹46,376 Cr
Category Apps Got Odds
QIB
75.13x subscribed
172 0 -
Ex. Anchor
139 0 -
Anchor
33 22 1 in 1.5
NII (HNI)
49.62x subscribed
1,52,244 6,919 1 in 22
bNII >₹10L
46,229 4,613 1 in 10
sNII <₹10L
1,06,015 2,306 1 in 46
Retail
12.65x subscribed
24,54,316 2,26,055 1 in 11
Employees
1.95x subscribed
469 469 All
TOTAL
49.35x subscribed
26,07,201 2,33,443 1 in 11
Subscription Insights

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 7.7% for a single lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 186.39x. This often signals long-term confidence from professional funds.

Day-wise Subscription History

Subscription trends over the last 3 days

Date Total
12 Aug 2026 DAY 3
70.26x
QIB 186.39x
BHNI 50.82x
SHNI 47.76x
Retail 12.96x
Employee 13.28x
11 Aug 2026 DAY 2
3.11x
QIB 1.39x
BHNI 4.31x
SHNI 7.01x
Retail 3.18x
Employee 4.78x
10 Aug 2026 DAY 1
0.83x
QIB 1x
BHNI 0.7x
SHNI 0.8x
Retail 0.77x
Employee 2.12x
IPO Guru App

IPO Guru on Android

Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.

Anchor Investor Allocation

Breakdown of shares allotted to anchor investors before the IPO opening

Anchor Investor Amt (₹ cr.) % Allocated
GOLDMAN SACHS FUNDS-GOLDMAN SACHS INDIA EQUITY PORTFOLIO ₹25.00 Cr 8.88%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND RCT-RPF ₹20.00 Cr 7.11%
INTERNATIONAL FINANCE CORPORATION ₹20.00 Cr 7.11%
BLACKROCK GLOBAL FUNDS-INDIA FUND ₹20.00 Cr 7.11%
MIRAE ASSET HEALTHCARE FUND ₹20.00 Cr 7.11%
ICICI PRUDENTIAL QUALITY FUND ₹15.00 Cr 5.33%
ICICI PRUDENTIAL EXPORTS & SERVICES FUND ₹12.00 Cr 4.26%
KOTAK CONTRA FUND ₹11.67 Cr 4.15%
KOTAK HEALTHCARE FUND ₹11.67 Cr 4.15%
KOTAK CONSUMPTION FUND ₹11.67 Cr 4.14%
HDFC PHARMA & HEALTHCARE FUND ₹11.14 Cr 3.96%
MOTILAL OSWAL LARGE CAP FUND ₹10.00 Cr 3.55%
TATA INDIA PHARMA & HEALTHCARE FUND ₹10.00 Cr 3.55%
NIPPON INDIA INNOVATION FUND ₹10.00 Cr 3.55%
HDFC VALUE FUND ₹8.75 Cr 3.11%
HDFC INNOVATION FUND ₹8.75 Cr 3.11%
EDELWEISS EQUITY SAVINGS FUND ₹7.50 Cr 2.66%
HDFC LIFE INSURANCE CO.LTD. ₹7.15 Cr 2.54%
BAJAJ LIFE INSURANCE LTD. ₹7.15 Cr 2.54%
WHITEOAK CAPITAL PHARMA & HEALTHCARE FUND ₹6.50 Cr 2.31%
HDFC MNC FUND ₹6.36 Cr 2.26%
GOLDMAN SACHS ETF TRUST-GOLDMAN SACHS INDIA EQUITY ETF ₹5.00 Cr 1.78%
WHITEOAK CAPITAL AGGRESSIVE HYBRID FUND ₹3.50 Cr 1.24%
ISIF EQUITY LONG-SHORT FUND ₹3.00 Cr 1.07%
AXIS MAX LIFE INSURANCE LTD.-SUSTAINABLE EQUITY FUND-ULIF02505/10/21 SUSTAINEQU104 ₹2.83 Cr 1.01%
AXIS MAX LIFE INSURANCE LTD.-ULIF00225/06/04 LIFEBALANC 104-BALANCED FUND ₹2.69 Cr 0.96%
EDELWEISS RECENTLY LISTED IPO FUND ₹2.50 Cr 0.89%
AXIS MAX LIFE INSURANCE LTD.-ULIF 01715/02/13 PENSMAXIMI 104-PENSION MAXIMISER FUND ₹0.92 Cr 0.33%
AXIS MAX LIFE INSURANCE LIMITED A/C UHG2S - INDIA CONSUMPTION OPPORTUNITIES FUND ₹0.21 Cr 0.08%
AXIS MAX LIFE INSURANCE LIMITED A/C UMFPH - HIGH GROWTH PENSION FUND ₹0.21 Cr 0.08%
AXIS MAX LIFE INSURANCE LTD.-ULGF 00217/04/06 GRATBALANC 104-GROUP GRATUITY BALANCED FUND ₹0.14 Cr 0.05%
MAX LIFE INSURANCE CO.LTD.-ULIF 01815/02/13 PENSPRESER 104-PENSION PRESERVER FUND ₹0.07 Cr 0.02%
MAX LIFE INSURANCE CO.LTD.-ULIF 00625/11/05 PENSBALANC 104-PENSION BALANCED FUND ₹0.07 Cr 0.02%
Total ₹281.45 Cr 100.02%

Molbio Diagnostics IPO Allotment Probability

Retail (up to ₹2 L)
1 in 11
~9.2% chance per PAN — 2,454,316 applicants for 226,055 allotment slots. Winners get exactly 1 lot (₹14,526) by SEBI lottery, however many lots you bid.
Small HNI (₹2–10 L)
1 in 46
~2.2% chance — 106,015 applicants for 2,306 allotment slots. Lottery allots the minimum S-HNI application of 14 lots (₹2 L) per winner; bidding bigger doesn't improve odds.
Big HNI (above ₹10 L)
1 in 50
~2% chance — 46,229 applicants for 936 allotment slots. Lottery allots the minimum B-HNI application of 69 lots (₹10 L) per winner; the rest is proportionate.
QIB (institutions)
186.39x
Proportionate allotment — at 186.39x, institutions receive ~0.5% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.

What Does This Subscription Data Mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.

Frequently Asked Questions

What is the current subscription status of Molbio Diagnostics IPO?

As of IPO close date (12 Aug, 2026), the Molbio Diagnostics IPO is subscribed 70.26x times. Retail category is 12.96x, and NII is 49.8x subscribed.

When is the allotment date for Molbio Diagnostics IPO?

The allotment for Molbio Diagnostics IPO is expected to be finalized on 13 August, 2026.

What is the GMP of Molbio Diagnostics?

The Grey Market Premium (GMP) for Molbio Diagnostics is currently ₹120, indicating a potential listing gain of 14.87%.

When will Molbio Diagnostics IPO list on the stock market?

Molbio Diagnostics is scheduled to list on BSE and NSE on 17 August, 2026.

What are the chances of getting allotment in Molbio Diagnostics IPO?

The retail category is oversubscribed at 12.96x, meaning allotment is by lottery. Statistically, approximately 1 in 13 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 186.39x mean for Molbio Diagnostics IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 186.39x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Molbio Diagnostics IPO allotment status?

After the allotment date (13 Aug, 2026), you can check your Molbio Diagnostics IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Molbio Diagnostics IPO Further

Track every stage of this IPO from subscription to listing:

Advertisement